SUVEN PHARMACEUTICALS
Back to All Ratios
|
SUVEN PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 22.11 | 28.56 | 30.66 | 34.35 | 35.89 |
What is the latest Profit After Tax (PAT) Margin ratio of SUVEN PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 22.11 |
| Mar2024 | 28.56 |
| Mar2023 | 30.66 |
| Mar2022 | 34.35 |
| Mar2021 | 35.89 |
How is Profit After Tax (PAT) Margin of SUVEN PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 22.11 | -22.58 | |
| Mar2024 | 28.56 | -6.85 | |
| Mar2023 | 30.66 | -10.74 | |
| Mar2022 | 34.35 | -4.29 | |
| Mar2021 | 35.89 | - | |
Other Financial Ratios of SUVEN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹21,974.6 Cr | -2.4% | -32.8% | -56.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,160.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,288.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,440.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,149.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,369.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -2.4% |
-32.8% |
-56.1% |
| SENSEX | 0.1% |
1.1% |
8.4% |
You may also like the below Video Courses